Tutkijat / Kuopio  | Airaksinen, O(lavi) |
| Alhava, E. |
| Alhonen, L. |
| Atalay, M(ustafa) |
| Cederberg, H. |
| Dunkel, L(eo) |
| Eskelinen, M(atti) |
| Giniatullin, R. |
| Gröhn, O(lli) |
| Harno, K. |
| Hartikainen, J(aana). |
| Hartikainen, J(uha). |
| Harvima, I. |
| Hiltunen, M(ikko) |
| Jääskeläinen, J(uha) E. |
| Jäkälä, P(ekka) |
| Jänne, J. |
| Jantunen, E(sa) |
| Järvinen, R. |
| Julkunen, P. |
| Kaikkonen, M(inna) U. |
| Kauhanen, J(ussi) |
| Kivipelto, M(iia) |
| Koistinaho, M. |
| Koivisto, T(imo) |
| Kokki, H. |
| Könönen, M. |
| Kosma, V(eli)-M(atti) |
| Kröger, H. |
| Kurl, S(udhir) |
| Kuusisto, J(ohanna) |
| Laakso, M(arkku) |
| Lakka, T(imo) A. |
| Lapinlampi, N(iina) |
| Laukkanen, J(ari) (UEF/KSSHP) |
| Levonen, A(nna)-L(iisa) |
| Lindgren, A(ntti) E. |
| Löppönen, H(eikki) |
| Mannermaa, A. |
| Manninen, H. |
| Mecklin, J(ukka)-P(ekka) |
| Moilanen, L(eena) |
| Mönkkönen, J. |
| Mykkänen, H. |
| Nuutinen, J. |
| Paajanen, H. |
| Paananen, J. |
| Palvimo, J.J. |
| Pelkonen, J(ukka) |
| Pihlajamäki, J(ussi) |
| Pihlajamäki, M. |
| Pitkänen, A(sla) |
| Punnonen, K. |
| Raatikainen K |
| Rauramaa, R. |
| Rissanen, T.T. |
| Roine, R(isto) P. |
| Ryynänen, O.P. |
| Saarikoski, S. |
| Schwab, U(rsula) |
| Sivenius, J. |
| Soininen, H(ilkka) |
| Soininen, P(asi) |
| Sorri, I. |
| Stancakova, A(lena) |
| Sulkava, R. |
| Sund, R(eijo) |
| Tammi, M. |
| Tanila, H(eikki) |
| Tiihonen, J(ari) |
| Uusaro, A. |
| Uusitupa, M. |
| Vanninen, R. |
| Vaskilampi, T. |
| Viinamäki, H(eimo) |
| Virtanen, M(arianna) |
| Voutilainen, R(aimo) |
| Voutilainen, S(ari) |
| Wahlfors, J. |
| Wirth, T. |
| Wong, G. |
| Ylä-Herttuala, S(eppo) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Glycated hemoglobin levels are mostly dependent on non-glycemic parameters in 9,398 Finnish men without diabetes. | Stancakova, A(lena) | 2395 days | save |  |  | |
| Genetic studies of body mass index yield new insights for obesity biology. | Stancakova, A(lena) | 2414 days | save | | | |
| New genetic loci link adipose and insulin biology to body fat distribution. | Stancakova, A(lena) | 2414 days | save | | | |
| Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. | Stancakova, A(lena) | 2428 days | save | | | |
| Association analysis of 29,956 individuals confirms that a low frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. | Stancakova, A(lena) | 2436 days | save | | | |
| Fasting and OGTT-Derived Measures of Insulin Resistance as Compared with the Euglycemic-Hyperinsulinemic Clamp in Non-diabetic Finnish Offspring of Type 2 Diabetic Individuals. | Stancakova, A(lena) | 2507 days | save | | | |
| Markers of Tissue-Specific Insulin Resistance Predict the Worsening of Hyperglycemia, Incident Type 2 Diabetes and Cardiovascular Disease. | Stancakova, A(lena) | 2536 days | save | | | |
| Defining the role of common variation in the genomic and biological architecture of adult human height. | Stancakova, A(lena) | 2545 days | save | | | |
| Genetics of metabolic syndrome. | Stancakova, A(lena) | 2595 days | save | | | |
| Family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage? | Stancakova, A(lena) | 2621 days | save | | | |
| A Central Role for GRB10 in Regulation of Islet Function in Man. | Stancakova, A(lena) | 2728 days | save | | | |
| Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. | Stancakova, A(lena) | 2850 days | save | | | |
| Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. | Stancakova, A(lena) | 2891 days | save | | | |
| Discovery and refinement of loci associated with lipid levels. | Stancakova, A(lena) | 2908 days | save | | | |
| Common variants associated with plasma triglycerides and risk for coronary artery disease. | Stancakova, A(lena) | 2908 days | save | | | |
| Gene× physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. | Stancakova, A(lena) | 2964 days | save | | | |
| Non-cholesterol sterol levels predict hyperglycemia and conversion to type 2 diabetes in finnish men. | Stancakova, A(lena) | 2997 days | save | | | |
| Mendelian Randomisation Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes. | Stancakova, A(lena) | 2998 days | save | | | |
| The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes. | Stancakova, A(lena) | 3025 days | save | | | |
| Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. | Stancakova, A(lena) | 3090 days | save | | | |
| Association of ketone body levels with hyperglycemia and type 2 diabetes in 9,398 Finnish men. | Stancakova, A(lena) | 3093 days | save | | | |
| Trans-ethnic fine-mapping of lipid Loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. | Stancakova, A(lena) | 3094 days | save | | | |
| A link between GIP and osteopontin in adipose tissue and insulin resistance. | Stancakova, A(lena) | 3163 days | save | | | |
| Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. | Stancakova, A(lena) | 3195 days | save | | | |
| Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. | Stancakova, A(lena) | 3229 days | save | | | |
| Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. | Stancakova, A(lena) | 3328 days | save | | | |
| Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men. | Stancakova, A(lena) | 3401 days | save | | | |
| A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. | Stancakova, A(lena) | 3419 days | save | | | |
| Hyperglycemia and a Common Variant of GCKR Are Associated With the Levels of Eight Amino Acids in 9,369 Finnish Men. | Stancakova, A(lena) | 3430 days | save | | | |
| Association Between Liver Insulin Resistance and Cardiovascular Risk Factors. | Stancakova, A(lena) | 3452 days | save | | | |
| No Interactions Between Previously Associated 2-h Glucose Gene Variants and Physical Activity or BMI on 2-h Glucose Levels. | Stancakova, A(lena) | 3479 days | save | | | |
| Genome-Wide Screen for Metabolic Syndrome Susceptibility Loci Reveals Strong Lipid Gene Contribution but No Evidence for Common Genetic Basis for Clustering of Metabolic Syndrome Traits. | Stancakova, A(lena) | 3484 days | save | | | |
| Serine/threonine protein kinase 25 (STK25): a novel negative regulator of lipid and glucose metabolism in rodent and human skeletal muscle. | Stancakova, A(lena) | 3487 days | save | | | |
| The Birth Weight Lowering C-Allele of rs900400 Near LEKR1 and CCNL1 Associates with Elevated Insulin Release following an Oral Glucose Challenge. | Stancakova, A(lena) | 3604 days | save | | | |
| Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children. | Stancakova, A(lena) | 3605 days | save | | | |
| Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. | Stancakova, A(lena) | 3644 days | save | | | |
| Genome-Wide Association Identifies Nine Common Variants Associated With Fasting Proinsulin Levels and Provides New Insights Into the Pathophysiology of Type 2 Diabetes. | Stancakova, A(lena) | 3650 days | save | | | |
| Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. | Stancakova, A(lena) | 3665 days | save | | | |
| Pleiotropic effects of GIP on islet function involve osteopontin. | Stancakova, A(lena) | 3682 days | save | | | |
| Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. | Stancakova, A(lena) | 3685 days | save | | | |
| SIRT3 Deficiency and Mitochondrial Protein Hyperacetylation Accelerate the Development of the Metabolic Syndrome. | Stancakova, A(lena) | 3686 days | save | | | |
| Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B. | Stancakova, A(lena) | 3707 days | save | | | |
| Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men. | Stancakova, A(lena) | 3741 days | save | | | |
| Evidence of how rs7575840 influences apolipoprotein B-containing lipid particles. | Stancakova, A(lena) | 3745 days | save | | | |
| Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men. | Stancakova, A(lena) | 3775 days | save | | | |
| A novel surrogate index for hepatic insulin resistance. | Stancakova, A(lena) | 3775 days | save | | | |
| The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies. | Stancakova, A(lena) | 3803 days | save | | | |
| Impact of positive family history and genetic risk variants on the incidence of diabetes: the Finnish Diabetes Prevention Study. | Stancakova, A(lena) | 3805 days | save | | | |
| A common variant in TFB1M is associated with reduced insulin secretion and increased future risk of type 2 diabetes. | Stancakova, A(lena) | 3878 days | save | | | |
| Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals. | Stancakova, A(lena) | 3940 days | save | | | |
| | 
report | « prev page 2 | | |
|
